It is not clear if the changes during gestation, such as increased IR and reduced adiponectin, contribute to the reduced adiponectin and increased ceramide post-menopause, exacerbating obesity-related effects on the heart. The gene discussed is ADIPOQ; the disease is obesity disorder.